Mark Cuban is Giving President Donald Trump’s New Direct-to-Consumer Online Drug Store A “B”-for Now.
Trump announce on tuesday that he plans to launch a government-Run website, Called Trumprx.gov, for Consumers to Buy Prescription Drugs Directly from Manufacturers on the site with the Involvement of Pharmacy Managers as intermediars. Acciting to NPRThe Administration Expects to Release the Website in 2026.
Cuban, The Billionaire Venture Capitalist, Communed on X That This Waled Be Good for Patients and Couldally Boost Business for His Cost Plus Drugs, which Runs on a Similar Model. He said that the administration has “some great people work on this project,” But he was “give the program, and what we know, as of today, a grade of B.”
“Why not an a? The Stock Price of PBMS didn’t get crushed,” wrote cuban. “Which Means, SO FAR, No One Expects MUCH Change for say. Which they Expect they will make up Lost Revens from Patients, Companies, and Other Payers Elsewhere.”
“IT’S STILL RIGGED TO BENEFIT The Big PBMS,” Cuban Added in Response to A Post Square IF Trump’s Operation Could Run Honestly with favor. “That Said, it has a chance if they are force pbms to change. If that happens, Trump Gets All the Credit and It Will Be Deserved.”
In an email to business insider, cuban said of Trumprx.gov, “iTis a lissting site .. and as long as they Include cost plus drugs, gioven we typically have the prices for more than 90% of prescriptions, I’m all for it!”
Nor part of the announcement, the White House said that pfizer plans to offer some of its drugs on Trumprx.gov and all of its drugs for medicaid at a reduced rate. The Deal Grants the Pharmaceutical Manufacturer a three -ear exemption from tariffs.
Related Stories
Business Insider Tells The Innovative Stories You Want To Know
Business Insider Tells The Innovative Stories You Want To Know
“The Large Majority of the Company’s Primary Care Treatments and Some Specialty Brands Will Be Offering at Savings that Will Range As 85% and On Average 50%,” The Company Said in a Press Release.
Cuban’s online Pharmacy, which he founded alongside radiologist Alexyansky in 2022, Cost Plus Drugs, Also Eliminates Intermediars and Offers Drugs at A 15% Markup Above the Manufacturer’s Wholesale Price.
Accounting to date from the Commonwealth end, Around 80% of Access to Drugs in the Us is Controlled by Three Large PBMS, Namely the unity Group-AWNED RX, CVS Health’s Caremark, and Cigna’s Express Scripts. Stock prices for all three parent companies did not substantially change throughout tuesday.
PBMS Receive Rebates from Drug Manufactures in Exchange for Giving favable placement on forms. Rebates are offten tied to the list price, therefore, higher-priced drugs can Generate Darker rebates. That creates an incentive for pbms to favor Certain Brand-Name Drugs Over Cheaper Generics or BioSimilars if the Manufacturer Offers a Bigger Rebate. Insurers Say these rebates Help Lower Overall Costs. Critics argue the system inflates prices and controls to Higher Insurance Premiums for Patients.
The White House did not immediately respond to a Request for Comments.